Drug Safety Governance: Framework and Development Path
- 1 The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing, China
- 2 The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing, China
- 3 The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, Nanjing, China
- 4 Institute of Regulatory Science, China Pharmaceutical University, Nanjing, China
Abstract
Objective: The necessity of shifting from management to governance of drug safety has gained a wide consensus in both academic and practical circles, but how to act and develop has not been adequately discussed and become a key issue that needs to be addressed nowadays. This article combines the theoretical essence of governance to establish an analytical framework of “initial conditions-joint action-governance effectiveness” based on governance theory to analyze and explain the connotation and mechanism of cross-sector cooperative governance of drug safety. Methods: The essence of governance lies in the creation of joint action capabilities through cross-sector cooperation, as well as the construction of a national drug safety governance action framework of “3 stages + 1 incubation period”. This article analyzes the connotation of each stage and possible problems or obstacles. Results: Three deep-seated challenges stem from the lack of information sharing, resource action sharing, and power sharing. Conclusion: In order to improve the modernization construction of China’s drug safety governance system and capacity, it is recommended to continuously improve Chinese drug safety governance in terms of governance norms, communication mechanisms, capacity development, and cross-sector coordination based on a holistic perspective.
- Agranoff, R. (2007). Managing within Networks. Georgetown University Press.
- Agranoff, R., & Mcguire, M. (2004). Collaborative Public Management: New Strategies for Local Governments. Georgetown University Press.
- Ansell, C., & Gash, A. (2008). Collaborative Governance in Theory and Practice. Journal of Public Administration Research & Theory, 18, 543-571. https://doi.org/10.1093/jopart/mum032
- Bryson, J. M., Crosby, B. C., & Stone, M. M. (2006). The Design and Implementation of Cross-Sector Collaborations: Propositions Form the Literature. Public Administration Review, 66, 44-55. https://doi.org/10.1111/j.1540-6210.2006.00665.x
- Cai, L. (2015). Collaborative Governance: A Solution to Complex Public Problems. Journal of Jinan (Philosophy and Social Science Edition), 37, 110-118.
- Chen, Y. F., Wang, Q., & Sun, X. F. (2015). UK Drug Regulatory Effectiveness Improvement Program and Its Inspirations. Pharmaceutical Herald, 34, 1261-1264.
- Dai, H. (2013). Accelerate the Construction of Food and Drug Safety Social Governance Pattern. China Food and Drug Administration, 8, 28-29.
- Duan, X. (2020). Constructive Dimensions and Co-Construction Strategies of Social Organization Participation in National Governance. Seeking, 5, 121-127.
- Emerson, K., Nabatchi, T., & Balogh S. (2012). An Integrative Framework for Collaborative Governance. Journal of Public Administration Research and Theory, 22, 1-29. https://doi.org/10.1093/jopart/mur011
- Fan, P. (2019). Interdependence and Cooperation: State-Society Relations since the Reform and Opening-Up. Yunnan Social Science, 1, 29-36, 186.
- Fierlbeck, K. (2010). Public Health and Collaborative Governance. Canadian Public Administration, 53, 1-19. https://doi.org/10.1111/j.1754-7121.2010.00110.x
- Guo, D. J. (2016). Collaborative Governance Is a Governance Model That Meets the Real Needs of China. Political Science Research, 1, 61-70+126-127.
- Himmelman, A. T. (1994). Communities Working Collaboratively for Change. In M. S. Herrman (Ed.), Resolving Conflict: Strategies for Local Government (pp. 27-47). County Management Association.
- Hu, Y. L. (2014). From the Welfare to People’s Livelihood Talking about the Change of Drug Safety Management System in New China. China Pharmaceutical Affairs, 9, 925-933.